Verve Therapeutics Correlations

VERV Stock

USD 6.31 0.14 2.17%

The current 90-days correlation between Verve Therapeutics and Adaptive Biotechnologies Corp is 0.38 (i.e., Weak diversification). The correlation of Verve Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Verve Therapeutics Correlation With Market

Average diversification

The correlation between Verve Therapeutics and DJI is 0.16 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Verve Therapeutics and DJI in the same portfolio, assuming nothing else is changed.

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Verve Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

For more information on how to buy Verve Stock please use our How to Invest in Verve Therapeutics guide.

Moving together with Verve Stock

0.61	A	Agilent Technologies Earnings Call Today	Pair Corr
0.76	FENC	Fennec Pharmaceuticals	Pair Corr
0.88	OPT	Opthea Earnings Call Today	Pair Corr
0.66	GANX	Gain Therapeutics	Pair Corr
0.89	LTRN	Lantern Pharma	Pair Corr
0.69	PHGE	Biomx Inc	Pair Corr
0.63	CPRX	Catalyst Pharmaceuticals Earnings Call Today	Pair Corr
0.64	DBVT	DBV Technologies Earnings Call This Week	Pair Corr
0.78	OBI	Ondine Biomedical	Pair Corr

Moving against Verve Stock

0.74	INZY	Inozyme Pharma	Pair Corr
0.63	ABOS	Acumen Pharmaceuticals	Pair Corr
0.51	ILMN	Illumina	Pair Corr
0.49	NAMSW	NewAmsterdam Pharma Upward Rally	Pair Corr
0.45	KURA	Kura Oncology	Pair Corr
0.63	CRNX	Crinetics Pharmaceuticals Earnings Call Today	Pair Corr
0.62	ADTX	Aditxt Inc	Pair Corr
0.62	TERN	Terns Pharmaceuticals	Pair Corr
0.54	TCRX	Tscan Therapeutics	Pair Corr
0.35	CTMX	CytomX Therapeutics	Pair Corr
0.34	STRO	Sutro Biopharma	Pair Corr
0.34	DAWN	Day One Biopharmaceu	Pair Corr
0.69	TLKMF	Telkom Indonesia Tbk	Pair Corr
0.41	PTAIY	Astra International Tbk Earnings Call Today	Pair Corr
0.35	PTITF	PT Indosat Tbk	Pair Corr

Related Correlations Analysis

	ADPT	BEAM	CRBU	SANA	NTLA	EDIT	CRSP	PRME	THRX	LIFE
ADPT		0.43	-0.77	0.46	-0.62	-0.45	-0.15	-0.34	0.0	0.0	ADPT
BEAM	0.43		-0.21	-0.07	0.07	0.17	0.31	-0.06	0.0	0.0	BEAM
CRBU	-0.77	-0.21		-0.44	0.9	0.56	0.52	0.68	0.0	0.0	CRBU
SANA	0.46	-0.07	-0.44		-0.45	-0.1	-0.01	-0.12	0.0	0.0	SANA
NTLA	-0.62	0.07	0.9	-0.45		0.75	0.75	0.76	0.0	0.0	NTLA
EDIT	-0.45	0.17	0.56	-0.1	0.75		0.75	0.55	0.0	0.0	EDIT
CRSP	-0.15	0.31	0.52	-0.01	0.75	0.75		0.65	0.0	0.0	CRSP
PRME	-0.34	-0.06	0.68	-0.12	0.76	0.55	0.65		0.0	0.0	PRME
THRX	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	THRX
LIFE	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		LIFE
	ADPT	BEAM	CRBU	SANA	NTLA	EDIT	CRSP	PRME	THRX	LIFE

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

NTLA	+ 0.9	CRBU
PRME	+ 0.76	NTLA
EDIT	+ 0.75	NTLA
CRSP	+ 0.75	NTLA
CRSP	+ 0.75	EDIT
PRME	+ 0.68	CRBU

High negative correlations

CRBU	- 0.77	ADPT
NTLA	- 0.62	ADPT
NTLA	- 0.45	SANA
EDIT	- 0.45	ADPT
SANA	- 0.44	CRBU
PRME	- 0.34	ADPT

Risk-Adjusted Indicators

There is a big difference between Verve Stock performing well and Verve Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Verve Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
ADPT	3.94	1.01	0.32	0.39	2.75	(5.47)	12.85	(4.92)	27.41
BEAM	3.35	0.46	0.11	(1.64)	3.51	(3.67)	8.04	(7.45)	21.42
CRBU	3.00	(0.64)	0.00	(1.54)	0.00	0.00	8.22	(7.09)	17.35
SANA	8.05	1.35	0.19	0.49	6.39	(11.15)	12.46	(11.88)	176.41
NTLA	3.59	(0.33)	0.00	(0.25)	0.00	0.00	7.84	(7.15)	22.98
EDIT	6.34	0.26	0.03	(0.32)	8.42	(7.74)	12.04	(9.59)	119.53
CRSP	2.88	(0.03)	0.00	(0.05)	0.00	0.00	6.48	(4.98)	19.32
PRME	4.17	(0.16)	0.00	(0.12)	0.00	0.00	10.03	(6.90)	19.38
THRX	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
LIFE	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00

Verve Therapeutics Corporate Management

Jennifer Robinson	Vice Communications	Profile
Kaitlin Duffy	Executive Resources	Profile
Troy Lister	Chief Officer	Profile
MD MPH	CoFounder Advisor	Profile
Joan MBA	Chief Officer	Profile
FACC MD	CoFounder	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC